Skip to main content

Table 1 Characteristics of patients with upper and lower limb metastases

From: Preoperative coagulation biomarkers associate with survival and pulmonary embolism after surgical treatment of non-spinal skeletal metastases

 

Fractures/ Patients

Mean age at operation in years (range)

Primary disease (number, %)

Site (number, %)

Upper limb

16/15

69 (32–96)

76 (57–89)

Kidney cancer (5, 33) Breast cancer (4, 27) Lung cancer (2, 13) Multiple myeloma (1, 7) Leiomyosarcoma (1, 7) Prostate cancer (1, 7) Unknown primary disease (1, 7)

Diaphyseal humerus (9, 56) Proximal humerus (6, 38) Distal humerus (1, 6)

Lower limb

97/92

68 (32–96)

Breast cancer (24, 26) Kidney cancer (21, 23) Lung cancer (12, 13) Multiple myeloma (10, 11) Colon cancer (4, 4) Prostate cancer (4, 4) Squamocellular cancer (4, 4) Leiomyosarcoma (2, 2) Uterine cancer (2, 2) Rectal cancer (2, 2) Lymphoma (1, 1) Pancreatic cancer (1, 1) Ventricular cancer (1, 1) Melanoma (1, 1) Urothelial cancer (1, 1) Clear cell sarcoma (1, 1)NET (1, 1)

Proximal femur (40, 41) Femoral neck (19, 20) Acetabulum (15, 16) Distal femur (11, 11) Diaphyseal femur (7, 7) Proximal tibia (3, 3) Multiple femoral lesions (1, 1) Diaphyseal tibia (1, 1)

  1. NET neuroendocrine tumor